Stockscreener 앱 받기
4.68
3.90%
-0.19
시간 외 거래:
4.70
0.02
+0.43%
전일 마감가:
$4.87
열려 있는:
$4.61
하루 거래량:
387.39K
Relative Volume:
1.03
시가총액:
$250.08M
수익:
$36.68M
순이익/손실:
$-36.78M
주가수익비율:
-4.0345
EPS:
-1.16
순현금흐름:
$-26.75M
1주 성능:
-10.17%
1개월 성능:
-22.52%
6개월 성능:
-4.88%
1년 성능:
+91.80%
1일 변동 폭
$4.48
$4.7999
1주일 범위
$4.48
$5.77
52주 변동 폭
$1.155
$10.37
Alpha Teknova Inc Stock (TKNO) Company Profile
명칭
Alpha Teknova Inc
전화
(831) 637-1100
주소
2451 BERT DRIVE, HOLLISTER
TKNO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TKNO
Alpha Teknova Inc
|
4.68 | 250.08M | 36.68M | -36.78M | -26.75M | -1.16 |
|
ZTS
Zoetis Inc
|
151.73 | 67.94B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.72 | 46.50B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
9.89 | 44.66B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
13.80 | 15.81B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
292.46 | 13.14B | 2.76B | 1.11B | 898.10M | 22.77 |
Alpha Teknova Inc Stock (TKNO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-10 | 개시 | Craig Hallum | Buy |
| 2024-03-12 | 다운그레이드 | BTIG Research | Buy → Neutral |
Alpha Teknova Inc 주식(TKNO)의 최신 뉴스
(TKNO) On The My Stocks Page - news.stocktradersdaily.com
Teknova And Pluristyx Launch PluriFreeze Cryopreservation System To Streamline Cell Therapy - Nasdaq
Teknova and Pluristyx Launch Proprietary PluriFreeze™ Cryopreservation System to Accelerate the Development of Cell Therapies - The Manila Times
Revolutionary Cell Therapy Preservation: Teknova's New PluriFreeze System Transforms Development Process - StockTitan
How the (TKNO) price action is used to our Advantage - news.stocktradersdaily.com
Alpha Teknova, Inc. (NASDAQ:TKNO) Sees Large Increase in Short Interest - Defense World
Sector Update: Health Care Stocks Decline Wednesday Afternoon - TradingView
Sector Update: Health Care -March 12, 2025 at 08:46 am EDT - Marketscreener.com
Alpha Teknova, Pluristyx Partner to Produce, Distribute PluriFreeze for Cell Therapies -March 12, 2025 at 04:23 am EDT - Marketscreener.com
Teknova and Pluristyx Announce Collaboration to Streamline the Manufacture of Next-Generation Cell Therapies - The Manila Times
Alpha Teknova and Pluristyx Announce Collaboration to Commercialize PluriFreeze Cryopreservation System for Cell Therapies - Nasdaq
Teknova, Pluristyx announce collaboration over next-generation cell therapies - TipRanks
Earnings Update: Here's Why Analysts Just Lifted Their Alpha Teknova, Inc. (NASDAQ:TKNO) Price Target To US$10.67 - Yahoo Finance
Alpha Teknova, Inc. SEC 10-K Report - TradingView
Alpha Teknova, Inc. (NASDAQ:TKNO) Just Reported And Analysts Have Been Lifting Their Price Targets - Simply Wall St
Alpha Teknova’s Earnings Call: Growth Amid Challenges - TipRanks
Alpha Teknova, Inc. (NASDAQ:TKNO) Q4 2024 Earnings Call Transcript - MSN
Positive Outlook for Alpha Teknova: Strong Financial Performance and Growth Potential - TipRanks
Alpha Teknova stock holds as KeyBanc maintains rating By Investing.com - Investing.com South Africa
Alpha Teknova stock holds as KeyBanc maintains rating - Investing.com India
Alpha Teknova: Strong Revenue Growth and Strategic Positioning Justify Buy Rating - TipRanks
Teknova Reports Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
Alpha Teknova: Q4 Earnings Snapshot - Midland Daily News
Alpha Teknova Reports Steady Revenue Growth in 2024 - TipRanks
Earnings call transcript: Alpha Teknova Q4 2024 shows revenue growth, stock edges up - Investing.com India
Alpha Teknova: Q4 Earnings Snapshot -March 04, 2025 at 05:12 pm EST - Marketscreener.com
Alpha Teknova, Inc. Q4 Loss Narrows - Nasdaq
Alpha Teknova, Inc. Reports 3% Revenue Growth for 2024 and Provides 2025 Guidance of $39-42 Million - Nasdaq
Can Teknova's 110% Clinical Solutions Growth Offset Continued Losses? - StockTitan
Stock Index Futures Mixed as Investors Weigh Trump Tariffs - TradingView
Alpha Teknova, Inc. (NASDAQ:TKNO) Short Interest Up 54.3% in February - Defense World
Alpha Teknova, Inc. (NASDAQ:TKNO) Stocks Pounded By 31% But Not Lagging Industry On Growth Or Pricing - Simply Wall St
Calculating The Fair Value Of Alpha Teknova, Inc. (NASDAQ:TKNO) - Simply Wall St
When the Price of (TKNO) Talks, People Listen - Stock Traders Daily
Teknova to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025 - The Manila Times
Alpha Teknova, Inc. Scheduled to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025 - Nasdaq
Q4 Earnings: Can Teknova's Critical Reagents Business Show Growth Momentum? - StockTitan
Nkcfo LLC Makes New Investment in Alpha Teknova, Inc. (NASDAQ:TKNO) - MarketBeat
Leading Driver In The Ready-To-Use Luria-Bertani LB Liquid Medium Market 2025: Surge In R&D Activities Driving - EIN News
Oruka Therapeutics (NASDAQ:ORKA) & Alpha Teknova (NASDAQ:TKNO) Head-To-Head Contrast - Defense World
Alpha Teknova (NASDAQ:TKNO) Shares Gap UpTime to Buy? - MarketBeat
Alpha Teknova (NASDAQ:TKNO) Earns Buy Rating from Analysts at Craig Hallum - MarketBeat
(TKNO) Technical Data - Stock Traders Daily
Here’s What Boosted Alpha Teknova (TKNO) in Q4 - Yahoo Finance
Alpha Teknova Inc (TKNO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
5.86%
자본화:
|
볼륨(24시간):